Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Donepezil on Speech Recognition in Cochlear Implant Users
NCT05438264Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2023
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of donepezil in bilateral sensorineural hearing loss (SNHL), sponsored by Vanderbilt University Medical Center. Started Mar 2023; status: completed.
02
Drugs
donepezil
03
Conditions
bilateral sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT05438264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438264.